<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<ibecs-document>
<record>
<header>
<identifier>ibc-054451</identifier>
<setSpec>0004-0614</setSpec>
</header>
<metadata xmlns="http://example.org/myapp/" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:dcterms="http://purl.org/dc/terms/" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xsi:schemaLocation="http://example.org/myapp/schema.xsd">
<dc:title xml:lang="en">Intravesical therapy: influence on superficial bladder cancer recurrence</dc:title>
<dc:description xml:lang="en">OBJECTIVES: To review the influence of various intravesical treatments on superficial bladder cancer recurrence. METHODS: We retrospectively reviewed 473 superficial bladder neoplasias. Based on diagnosis and transurethral resection of bladder tumor (TUR BT), and depending on pathology, we proposed different adjuvant treatment and follow-up schemes. RESULTS: The following factors were independent risk factors for a longer recurrence-free time: intravesical instillations, high dose BCG, and maintenance therapy in comparison to induction. CONCLUSIONS: The use of intravesical instillations independently increases the time to recurrence. It was demonstrated that recurrence was significantly later when high dose BCG and maintenance therapy were employed</dc:description>
<dc:creator>Regadera Sejas, Javier</dc:creator>
<dc:creator>Escaf Barmadah, Safwan</dc:creator>
<dc:creator>Jalón Monzón, Antonio</dc:creator>
<dc:creator>García Rodríguez, Jorge</dc:creator>
<dc:creator>Martínez Gómez, Francisco Javier</dc:creator>
<dc:creator>González Álvarez, Roberto Carlos</dc:creator>
<dc:creator>Fernández Gómez, Jesús María</dc:creator>
<dc:creator>Sánchez Trilla, Alberto</dc:creator>
<dc:language>es</dc:language>
<dc:description xml:lang="es">OBJETIVOS    Revisar la influencia de distintos tratamientos endovesicales sobre la recurrencia del cáncer vesical superficial.         METODOS    Se revisaron retrospectivamente un total de 473 neoplasias vesicales superficiales. A partir del diagnóstico y la RTU vesical, y en función del resultado anatomopatológico, se plantearon distintos esquemas de seguimiento y tratamiento complementario.         RESULTADOS    Resultaron independientes para explicar mayor tiempo libre hasta la recurrencia superficial los siguientes factores: empleo de lavados endovesicales, tratamiento con dosis altas de BCG y terapia de mantenimiento frente a inducción.         CONCLUSIONES    El empleo de instilaciones vesicales incrementaron de forma independiente el tiempo hasta la recidiva. Se demostró que la recurrencia se produjo significativamente más tarde cuando se habían empleado dosis altas de BCG y terapia de mantenimiento</dc:description>
<dc:source>Arch Esp Urol;60(1): 36-43, ene.-feb. 2007. ilus, tab</dc:source>
<dc:identifier>ibc-054451</dc:identifier>
<dc:title xml:lang="es">Terapia endovesical: influencia sobre la recidiva en el cáncer vesical superficial</dc:title>
<dc:subject>^d974^s22000</dc:subject>
<dc:subject>^d28611</dc:subject>
<dc:subject>^d23093^s22000</dc:subject>
<dc:subject>^d27905^s22000</dc:subject>
<dc:subject>^d21034</dc:subject>
<dc:subject>^d29961^s22000</dc:subject>
<dc:subject>^d1774^s22057</dc:subject>
<dc:subject>^d9557^s22054</dc:subject>
<dc:subject>^d1774^s22054</dc:subject>
<dc:subject>^d19057</dc:subject>
<dc:subject>^d14384</dc:subject>
<dc:type>article</dc:type>
<dc:date>200702</dc:date>
</metadata>
</record>
</ibecs-document>
